OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular mechanisms associated with chemoresistance in esophageal cancer
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 31
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 92
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 92
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Rui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Rui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization
Ziyu Liu, Jie Liu, Yanhao Wu, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113933-113933
Closed Access
Ziyu Liu, Jie Liu, Yanhao Wu, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113933-113933
Closed Access
Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies
Xue-Man Dong, Lin Chen, Yuxin Xu, et al.
Cancer Gene Therapy (2025)
Closed Access
Xue-Man Dong, Lin Chen, Yuxin Xu, et al.
Cancer Gene Therapy (2025)
Closed Access
Associations between vascular endothelial growth factor polymorphisms and response to 5-FU-based pharmaceutical therapy in esophageal squamous cell carcinoma: A meta-analysis
Yonghui Li, Qiang Guo, Haibo Wang, et al.
Tumori Journal (2025)
Closed Access
Yonghui Li, Qiang Guo, Haibo Wang, et al.
Tumori Journal (2025)
Closed Access
Cell-based Immunotherapy in Esophageal Cancer
Masoud Lahouty, Amirhossein Soleymanzadeh, Sohrab Kazemi, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Masoud Lahouty, Amirhossein Soleymanzadeh, Sohrab Kazemi, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Cellular and molecular basis of therapeutic approaches to breast cancer
Mohamed El‐Tanani, Arwa Omar Al Khatib, Belal O. Al-Najjar, et al.
Cellular Signalling (2022) Vol. 101, pp. 110492-110492
Open Access | Times Cited: 25
Mohamed El‐Tanani, Arwa Omar Al Khatib, Belal O. Al-Najjar, et al.
Cellular Signalling (2022) Vol. 101, pp. 110492-110492
Open Access | Times Cited: 25
Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival
Francisco Ramos‐Martín, Nicola D′Amelio
Microbiology Research (2023) Vol. 14, Iss. 2, pp. 507-542
Open Access | Times Cited: 13
Francisco Ramos‐Martín, Nicola D′Amelio
Microbiology Research (2023) Vol. 14, Iss. 2, pp. 507-542
Open Access | Times Cited: 13
Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors
Wen-Shang Liu, Lili Wu, Cui-Min Chen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100751-100751
Open Access | Times Cited: 13
Wen-Shang Liu, Lili Wu, Cui-Min Chen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100751-100751
Open Access | Times Cited: 13
Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis
Yuming Wang, Qi-Wu Zhao, Zhiyong Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5787-5808
Open Access | Times Cited: 17
Yuming Wang, Qi-Wu Zhao, Zhiyong Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5787-5808
Open Access | Times Cited: 17
Thymol Enhances 5-Fluorouracil Cytotoxicity by Reducing Migration and Increasing Apoptosis and Cell Cycle Arrest in Esophageal Cancer Cells: An In-vitro Study
Ghazaleh pouyamanesh, Nima Ameli, Yekta Metanat, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access | Times Cited: 2
Ghazaleh pouyamanesh, Nima Ameli, Yekta Metanat, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access | Times Cited: 2
Self-sustaining long-term 3D epithelioid cultures reveal drivers of clonal expansion in esophageal epithelium
Albert Herms, David Fernández‐Antorán, Maria P. Alcolea, et al.
Nature Genetics (2024)
Open Access | Times Cited: 2
Albert Herms, David Fernández‐Antorán, Maria P. Alcolea, et al.
Nature Genetics (2024)
Open Access | Times Cited: 2
Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy
Wenhao Liao, Yuchen Li, Jing Wang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4163-4193
Open Access | Times Cited: 12
Wenhao Liao, Yuchen Li, Jing Wang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4163-4193
Open Access | Times Cited: 12
Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells
Jhenifer Santos dos Reis, Marcos André Rodrigues da Costa Santos, Kelli Monteiro da Costa, et al.
Matrix Biology (2023) Vol. 118, pp. 47-68
Open Access | Times Cited: 7
Jhenifer Santos dos Reis, Marcos André Rodrigues da Costa Santos, Kelli Monteiro da Costa, et al.
Matrix Biology (2023) Vol. 118, pp. 47-68
Open Access | Times Cited: 7
Cancer organoid applications to investigate chemotherapy resistance
K Harada, Naoya Sakamoto
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
K Harada, Naoya Sakamoto
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
Esophageal cancer stem cells reduce hypoxia-induced apoptosis by inhibiting the GRP78-perk-eIF2α-ATF4-CHOP pathway in vitro
Ruijiang Lin, Minjie Ma, Biao Han, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 4, pp. 1669-1693
Open Access | Times Cited: 6
Ruijiang Lin, Minjie Ma, Biao Han, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 4, pp. 1669-1693
Open Access | Times Cited: 6
Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions
Jinxin Tang, Jieyu He, Chengyao Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Jinxin Tang, Jieyu He, Chengyao Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Capivasertib reverses chemotherapy-induced esophageal cancer resistance via inhibiting Akt-associated Mcl-1 upregulation
Jindan Kai, Kai Kang, Zhixiao Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33567-e33567
Open Access | Times Cited: 1
Jindan Kai, Kai Kang, Zhixiao Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33567-e33567
Open Access | Times Cited: 1
Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma
Kewei Song, Chenhui Ma, Baohong Gu, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 31, pp. 3069-3079
Open Access | Times Cited: 4
Kewei Song, Chenhui Ma, Baohong Gu, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 31, pp. 3069-3079
Open Access | Times Cited: 4
Epithelioids: Self-sustaining 3D epithelial cultures to study long-term processes
Albert Herms, David Fernández‐Antorán, Maria P. Alcolea, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Albert Herms, David Fernández‐Antorán, Maria P. Alcolea, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Exosomal circular RNAs: A key player in cancer drug resistance
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, et al.
Gene Reports (2023) Vol. 33, pp. 101835-101835
Closed Access | Times Cited: 2
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, et al.
Gene Reports (2023) Vol. 33, pp. 101835-101835
Closed Access | Times Cited: 2
WITHDRAWN: Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Research Square (Research Square) (2024)
Open Access
Research Square (Research Square) (2024)
Open Access
Drug resistance‑related gene targets and molecular mechanisms in the A2780/Taxol‑resistant epithelial ovarian cancer cell line
Ruihui Yang, Huainian Zhang, Ze-xin Chase Chen, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access
Ruihui Yang, Huainian Zhang, Ze-xin Chase Chen, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access
Nanoparticle delivery of si-Notch1 modulates metabolic reprogramming to affect 5-FU resistance and cell pyroptosis in colorectal cancer
Dandan Li, Jiacheng Jin, Xuan-wen Liu, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access
Dandan Li, Jiacheng Jin, Xuan-wen Liu, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access
